This is a preview of subscription content, log in via an institution to check access.
Reference
At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt. Internet Document : 27 Jan 2014. Available from: URL: http://www.bloomberg.com
Rights and permissions
About this article
Cite this article
US payers set to battle against high-priced treatments?. PharmacoEcon Outcomes News 695, 11 (2014). https://doi.org/10.1007/s40274-014-1020-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1020-y